Searchable abstracts of presentations at key conferences in endocrinology

ea0029p826 | Endocrine tumours and neoplasia | ICEECE2012

Profile of Patients with Pheochromocytoma & Paraganglioma

Gupta P. , Khurana M. , Ammini A. , Sharma S.

Introduction: There is scarcity of information regarding the profile of patients with Pheochromocytoma and paraganglioma from India.Aim: To study clinical profile of patients with Pheochromocytoma (PHEO)/Paraganglioma (PGL) attending the AIIMS hospital.Methodology:: Study protocol was approved by the AIIMS ethics committee. Written informed consent was taken from patients (parents in case of children). Patients of PHEO & PGL at...

ea0029p792 | Endocrine tumours and neoplasia | ICEECE2012

Novel 45A>G & 46D>G mutation of SDHB Exon-1 in a Patient with Urinary Bladder & Posterior Mediastinum Paraganglioma.

Gupta P. , Khurana M. , Ammini A. , Singh P. , Kumar R. , Khandelwal D.

Introduction: Extra adrenal paraganglioma (PGL) account for approximately 15% of all pheochromocytoma. Urinary bladder & mediastinum are rarest form of PGL. We present a case of bladder &Mediastinal PGL with a novel mutation in exon 1 of SDHB gene.Case Report: 18 years old male patient was admitted with five years episodic symptoms of headache, sweating, and palpitations, especially after urination. He also complained of postural dizziness for la...

ea0015p14 | Bone | SFEBES2008

Effects of 6 months strontium ranelate administration on phosphocalcium metabolism in postmenopausal women with reduced bone density

Joshi AA , Ahmad AM , Whittingham P , Gupta V , Hamilton A , Durham BH , Fraser WD , Vora JP

Introduction: Strontium ranelate (SR) is a dual action bone agent that increases bone formation and reduces bone resorption. Previous long term studies with SR have demonstrated minimal reductions in parathyroid hormone (PTH) and adjusted calcium (ACa) levels with increase in phosphate (PO4) concentrations, but the exact mechanism of action of SR remains unclear. Postmenopausal women with low bone mineral density (BMD) have relatively high circulating PTH concentrat...

ea0011p238 | Cytokines and growth factors | ECE2006

The depot specific expression of NPY in human adipose tissue and its upregulation under hyperinsulinaemic conditions in isolated human adipocytes

Kos K , Harte AL , Gupta P , O’Hare P , McTernan PG , Kumar S

Neuropeptide Y (NPY) is a centrally expressed peptide with potent orexigenic properties, released post-prandially to stimulate appetite, regulated by insulin and altered by obesity. NPY is expressed in adipose tissue which suggests it may have a potential effect on altering appetite control in obesity. To date no study has investigated NPY and its regulation in human adipose tissue. Therefore, the aims of this study were to 1) determine the depot-specific expression in abdomin...

ea0009oc7 | Oral Communication 1: Diabetes and metabolism | BES2005

Calcitonin Gene Related Peptide (CGRP)II mRNA in human subcutaneous adipose tissue is altered by menopausal status

Gupta P , Harte A , Hill M , Barnett A , Sturdee D , Kumar S , McTernan P

CGRP, a potent vasodilator, is elevated in the intense periods during menopausal hot flushes and presently represents a candidate mediator of vasomotor symptoms. However due to the short half-life of CGRP, the local paracrine effects may be more important than systemic effects. These local paracrine effects may be mediated in conjunction with adipose tissue, due to close physical proximity with the vasculature; as well as altered oestrogen metabolism following menopause. There...

ea0004oc12 | Endocrine tumours and neoplasia | SFE2002

THE EFFECTS OF GHRELIN ON EXPRESSION OF GROWTH HORMONE, IGF-1 AND TUMOUR ASSOCIATED GENES IN CULTURED NORMAL AND MALIGNANT BREAST TISSUE EXPLANTS

Sen|#Gupta P , Laban C , Ogunkolade B , Bustin S , Carpenter R , Jenkins P

Background: Previously we have demonstrated expression of GH, IGF-1 and ghrelin, but not GHRH, in normal and malignant breast tissue. In vitro studies have suggested an inhibitory effect of ghrelin on proliferation of breast cancer cell lines. However the use of cell lines and dose of ghrelin may not represent physiological conditions.Objectives: (1) To establish a viable method for culturing fresh breast tissue explants, (2) to use this to investigate t...

ea0007p106 | Endocrine tumours and neoplasia | BES2004

The effects of ghrelin on IGF-I expression in normal and malignant breast tissue explants

Laban C , Edwards C , Seb|#Gupta P , McCarthy K , Ogunkolade B , Bustin S , Edwards R , Carpenter R , Jenkins P

Background: The GH/IGF-I axis has been implicated in the development of breast cancer. However the regulation of local expression of the GH/IGF-I axis in breast tissue is unknown. In vitro studies have suggested an inhibitory effect of ghrelin on the proliferation of breast cancer cell lines, although the mechanisms for this action are unknown.Aims: Using a physiologically relevant culture system for breast tissue explants, to investigate the effects of ...

ea0024oc1.1 | Oral Communications 1 | BSPED2010

Best Abstract Winner

Ng S M , Turner M A , Gamble C , Didi M , Newland P , Victor S , Manning D , Settle P , Gupta R , Abernethy L , Parkes L , Atkinson J , Weindling A M

Background: Low thyroid hormone concentrations in the first few weeks of life in preterm infants may be linked with poor neurodevelopment. We conducted a multi-centred randomised controlled trial of thyroxine (T4) supplementation in babies born under 28-weeksÂ’ gestation (TIPIT study). A post hoc subgroup analysis was undertaken to examine brain growth and development.Methods: Seventy-eight infants received T4 supplementation an...